Single-cell RNA sequencing: one step closer to the clinic

Romanos Sklavenitis-Pistofidis^{1

2}, Gad Getz^{2

3}, Irene Ghobrial^{4

5

6}

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
² Broad Institute of MIT and Harvard, Cambridge, MA, USA.
³ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.
⁵ Broad Institute of MIT and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.
⁶ Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.

Comment

Romanos Sklavenitis-Pistofidis et al. Nat Med. 2021 Mar.

. 2021 Mar;27(3):375-376.

doi: 10.1038/s41591-021-01276-y.

Romanos Sklavenitis-Pistofidis^{1

2}, Gad Getz^{2

3}, Irene Ghobrial^{4

5

6}

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
² Broad Institute of MIT and Harvard, Cambridge, MA, USA.
³ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.
⁵ Broad Institute of MIT and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.
⁶ Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.

No abstract available

Comment on

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing.
Cohen YC, Zada M, Wang SY, Bornstein C, David E, Moshe A, Li B, Shlomi-Loubaton S, Gatt ME, Gur C, Lavi N, Ganzel C, Luttwak E, Chubar E, Rouvio O, Vaxman I, Pasvolsky O, Ballan M, Tadmor T, Nemets A, Jarchowcky-Dolberg O, Shvetz O, Laiba M, Shpilberg O, Dally N, Avivi I, Weiner A, Amit I. Cohen YC, et al. Nat Med. 2021 Mar;27(3):491-503. doi: 10.1038/s41591-021-01232-w. Epub 2021 Feb 22. Nat Med. 2021. PMID: 33619369 Free PMC article.

1. National Cancer Institute Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/mulmy.html (accessed 20 January 2021).
1. Kumar, S. K. & Rajkumar, S. V. Nat. Rev. Clin. Oncol. 15, 409–421 (2018). - DOI
1. Nunnelee, J. Z. Q. et al. Blood 134, 4573 (2019). - DOI
1. Thorsteinsdottir, S. et al. Haematologica 103, e412–e415 (2018). - DOI
1. Liu, Y., Tang, C. H., Qiu, H., Siggins, S. & Hou, H. A. Sci. Rep. 11, 1112 (2021). - DOI